Bio-Techne Shareholders Give Green Light for Merck KGaA Acquisition: A New Era Begins#United_States#Acquisition#Minneapolis#Bio-Techne#Merck_KGaA
Bio-Techne Shareholders Give Green Light for Merck KGaA Acquisition: A New Era Begins
Bio-Techne has secured shareholder approval for its acquisition by Merck KGaA, marking a significant step for a more innovative life sciences collaboration. Discover the details.
third-news.com
September 23, 2026 at 2:24 PM
Bio-Techne Shareholders Give Green Light for Merck KGaA Acquisition: A New Era Begins#United_States#Acquisition#Minneapolis#Bio-Techne#Merck_KGaA
🚨 $TECH
On September 23, 2026, Bio-Techne issued a press release announcing Bio-Techne shareholders’ approval of the Merger Agreement Proposal.
On September 23, 2026, Bio-Techne issued a press release announcing Bio-Techne shareholders’ approval of the Merger Agreement Proposal.
SEC Filing: TECH
Click to view the official SEC document.
www.sec.gov
September 23, 2026 at 9:10 PM
🚨 $TECH
On September 23, 2026, Bio-Techne issued a press release announcing Bio-Techne shareholders’ approval of the Merger Agreement Proposal.
On September 23, 2026, Bio-Techne issued a press release announcing Bio-Techne shareholders’ approval of the Merger Agreement Proposal.
🚨 JUST IN: $TECH
Bio-Techne shareholders approve Merck KGaA acquisition; HSR waiting period expired
#SEC #stocks #investing #TECH #Mergers
🔗 secwatch.observer
Bio-Techne shareholders approve Merck KGaA acquisition; HSR waiting period expired
#SEC #stocks #investing #TECH #Mergers
🔗 secwatch.observer
September 23, 2026 at 10:39 PM
🚨 JUST IN: $TECH
Bio-Techne shareholders approve Merck KGaA acquisition; HSR waiting period expired
#SEC #stocks #investing #TECH #Mergers
🔗 secwatch.observer
Bio-Techne shareholders approve Merck KGaA acquisition; HSR waiting period expired
#SEC #stocks #investing #TECH #Mergers
🔗 secwatch.observer
Germany's Merck to buy Bio-Techne for $11.3 billion reut.rs/4amGjfX
Germany's Merck to buy Bio-Techne for $11.3 billion
Merck KGaA has agreed to acquire biotech firm Bio-Techne Corp for $11.3 billion, the German science and healthcare firm said in a statement on Thursday.
reut.rs
June 25, 2026 at 10:50 AM
Germany's Merck to buy Bio-Techne for $11.3 billion reut.rs/4amGjfX
In Brief This Week: Precure, Mayo Clinic, Thermo, Helix, Merck, Bionano, MSK, Bio-Techne, More
In Brief This Week: Precure, Mayo Clinic, Thermo, Helix, Merck, Bionano, MSK, Bio-Techne, More
News items for the week of September 21, 2026: Precure, Mayo Clinic, Thermo Fisher, Helix, Merck, Bionano, MSK, More
ebx.sh
September 25, 2026 at 6:52 PM
In Brief This Week: Precure, Mayo Clinic, Thermo, Helix, Merck, Bionano, MSK, Bio-Techne, More
Full list of entities I follow in #LiquidBiopsy #EarlyCancerScreening Grail Bio $GRAL, Singlera, Freenome, Helio Health, Geneoscopy, Exact Sciences $EXAS, Flatiron Health, $CDNA CareDx, $VCYT Veracyte, Bio-Techne $TECH, Tempus AI $TEM, Guardant Health $GH, Biodesix $BDSX, Sophia Genetics $SOPH
Thank you all for following! Keep it up for content around #biotech #NextGenSequecing #SingleCell #SpatialBiology #NextGenProteomics #SynBio #DNAWrite #BlueSci #SciSky #AI #ComputeAcceleration and the occasional meme.
February 10, 2025 at 10:12 AM
Full list of entities I follow in #LiquidBiopsy #EarlyCancerScreening Grail Bio $GRAL, Singlera, Freenome, Helio Health, Geneoscopy, Exact Sciences $EXAS, Flatiron Health, $CDNA CareDx, $VCYT Veracyte, Bio-Techne $TECH, Tempus AI $TEM, Guardant Health $GH, Biodesix $BDSX, Sophia Genetics $SOPH
At what point can I trade eggs for RNAscope kits from Bio-techne?
February 28, 2025 at 5:38 PM
At what point can I trade eggs for RNAscope kits from Bio-techne?
Evercore initiates coverage of Bio-Techne, sees growth in Spatial biology, article at @genomeweb.bsky.social
March 19, 2025 at 4:29 AM
Evercore initiates coverage of Bio-Techne, sees growth in Spatial biology, article at @genomeweb.bsky.social
DOJ Seeks Breakup of Google and Chrome — The Justice Department aims to force Google to sell Chrome to address its illegal search monopoly.
https://www.barchart.com/story/news/29704327/are-wall-street-analysts-predicting-bio-techne-stock-will-climb-or-sink
https://www.barchart.com/story/news/29704327/are-wall-street-analysts-predicting-bio-techne-stock-will-climb-or-sink
November 21, 2024 at 6:06 PM
DOJ Seeks Breakup of Google and Chrome — The Justice Department aims to force Google to sell Chrome to address its illegal search monopoly.
https://www.barchart.com/story/news/29704327/are-wall-street-analysts-predicting-bio-techne-stock-will-climb-or-sink
https://www.barchart.com/story/news/29704327/are-wall-street-analysts-predicting-bio-techne-stock-will-climb-or-sink
Germany's Merck to buy Bio-Techne for $11.3 billion
Germany's Merck to buy Bio-Techne for $11.3 billion
Merck KGaA has agreed to acquire biotech firm Bio-Techne for $11.3 billion, the German science and healthcare firm said in a statement on Thursday.
cnb.cx
June 25, 2026 at 10:45 AM
Germany's Merck to buy Bio-Techne for $11.3 billion
🏠 Expert shares breakdown on navigating the housing market.
🏢 Bio-Techne shareholders approve acquisition by Merck KGaA.
📊 NSE launches Market Lens tool to screen 2,000+ stocks.
🤖 Healthcare Triangle signs LOI to acquire Roboticom.
🏢 Bio-Techne shareholders approve acquisition by Merck KGaA.
📊 NSE launches Market Lens tool to screen 2,000+ stocks.
🤖 Healthcare Triangle signs LOI to acquire Roboticom.
September 23, 2026 at 4:47 PM
🏠 Expert shares breakdown on navigating the housing market.
🏢 Bio-Techne shareholders approve acquisition by Merck KGaA.
📊 NSE launches Market Lens tool to screen 2,000+ stocks.
🤖 Healthcare Triangle signs LOI to acquire Roboticom.
🏢 Bio-Techne shareholders approve acquisition by Merck KGaA.
📊 NSE launches Market Lens tool to screen 2,000+ stocks.
🤖 Healthcare Triangle signs LOI to acquire Roboticom.
📈 Bio-Techne $72.56 Update
Bio-Techne's shares trade at $72.56, reflecting a 39.5% gain. The company generated $1.22 billion in revenue over the past year. Its stock has outperformed the S&P 500 by 21.5% in six months.
https://finance.yahoo.com/markets/stocks/articles/3-reasons-sell-tech-1-134102
Bio-Techne's shares trade at $72.56, reflecting a 39.5% gain. The company generated $1.22 billion in revenue over the past year. Its stock has outperformed the S&P 500 by 21.5% in six months.
https://finance.yahoo.com/markets/stocks/articles/3-reasons-sell-tech-1-134102
September 23, 2026 at 7:25 PM
📈 Bio-Techne $72.56 Update
Bio-Techne's shares trade at $72.56, reflecting a 39.5% gain. The company generated $1.22 billion in revenue over the past year. Its stock has outperformed the S&P 500 by 21.5% in six months.
https://finance.yahoo.com/markets/stocks/articles/3-reasons-sell-tech-1-134102
Bio-Techne's shares trade at $72.56, reflecting a 39.5% gain. The company generated $1.22 billion in revenue over the past year. Its stock has outperformed the S&P 500 by 21.5% in six months.
https://finance.yahoo.com/markets/stocks/articles/3-reasons-sell-tech-1-134102
"stock prices of many genomics tools firms fell on Monday in response to the NIH directive. According to a research note issued by investment bank UBS Securities yesterday, firms w/ the most exposure to NIH funding include 10x Genomics, Pacific Biosciences, Illumina, Bio-Techne, Bruker, & Qiagen."
February 10, 2025 at 10:09 PM
"stock prices of many genomics tools firms fell on Monday in response to the NIH directive. According to a research note issued by investment bank UBS Securities yesterday, firms w/ the most exposure to NIH funding include 10x Genomics, Pacific Biosciences, Illumina, Bio-Techne, Bruker, & Qiagen."
Thanks to all of our speakers (still trying to find their new handles), including Liz Jury, @bendinglab.bsky.social, Fred Sheedy, @labliston.bsky.social. Thank you too, to our sponsors from the University of Manchester, @britsocimm.bsky.social, Integra & Bio-Techne 10/🧵
November 19, 2024 at 10:54 PM
Thanks to all of our speakers (still trying to find their new handles), including Liz Jury, @bendinglab.bsky.social, Fred Sheedy, @labliston.bsky.social. Thank you too, to our sponsors from the University of Manchester, @britsocimm.bsky.social, Integra & Bio-Techne 10/🧵
CDW Corp-20.32%
Cencora Inc-17.38%
Bio-Techne Corp-16.36%
Arista Networks Inc-13.61%
Skyworks Solutions-10.47%
地獄組
#S&P500急落暴騰
Cencora Inc-17.38%
Bio-Techne Corp-16.36%
Arista Networks Inc-13.61%
Skyworks Solutions-10.47%
地獄組
#S&P500急落暴騰
May 7, 2026 at 4:20 AM
CDW Corp-20.32%
Cencora Inc-17.38%
Bio-Techne Corp-16.36%
Arista Networks Inc-13.61%
Skyworks Solutions-10.47%
地獄組
#S&P500急落暴騰
Cencora Inc-17.38%
Bio-Techne Corp-16.36%
Arista Networks Inc-13.61%
Skyworks Solutions-10.47%
地獄組
#S&P500急落暴騰
Bio-Techne Corporation Special meeting (2026-09-23) - NBIM voted against management:
• Against Management proposal: Advisory Vote on Golden…
See full meeting details.
• Against Management proposal: Advisory Vote on Golden…
See full meeting details.
September 21, 2026 at 8:20 AM
Bio-Techne Corporation Special meeting (2026-09-23) - NBIM voted against management:
• Against Management proposal: Advisory Vote on Golden…
See full meeting details.
• Against Management proposal: Advisory Vote on Golden…
See full meeting details.
In the past year, Merck KGaA has turned its attention to growing its business in supplies for the life sciences industry.
#chemsky 🧪
#chemsky 🧪
Merck KGaA to buy Bio-Techne for around $11 billion
All-cash deal will strengthen the German company’s life sciences portfolio
cen.acs.org
June 26, 2026 at 9:06 PM
In the past year, Merck KGaA has turned its attention to growing its business in supplies for the life sciences industry.
#chemsky 🧪
#chemsky 🧪
Excited to present this @biotechne #webinar on best practices using #ipscs in #stemcell #research
bit.ly/40n5zxN
bit.ly/40n5zxN
Webinar: iPSC Culture and Differentiation Best Practices | Bio-Techne | Bio-Techne
Join this expert-led webinar and discover key techniques for overcoming the challenges of maintaining pluripotency and achieving successful differentiation.
bit.ly
January 21, 2025 at 1:34 AM
Excited to present this @biotechne #webinar on best practices using #ipscs in #stemcell #research
bit.ly/40n5zxN
bit.ly/40n5zxN
Merck KGaA is buying life science company Bio-Techne for $11.3B, paying $73 a share in its largest acquisition in a decade.
Merck KGaA makes largest deal in a decade in $11.3B buy for Bio-Techne
Merck KGaA to acquire Bio-Techne for $11.3B, its largest deal in a decade, expanding in life science tools, spatial biology and diagnostics.
endpoints.news
June 25, 2026 at 7:07 PM
Merck KGaA is buying life science company Bio-Techne for $11.3B, paying $73 a share in its largest acquisition in a decade.
Ślimak. Ten w uchu. Wypreparowany i oznaczony metodą immunohistochemii. Autorem niezwykłego zdjęcia, wykonanego za pomocą mikroskopii fluorescencyjnej LSFM, jest ©️Ronald Pouyo z Uniwersytetu w Liege i firmy Bio-Techne.
May 8, 2025 at 4:01 PM
Ślimak. Ten w uchu. Wypreparowany i oznaczony metodą immunohistochemii. Autorem niezwykłego zdjęcia, wykonanego za pomocą mikroskopii fluorescencyjnej LSFM, jest ©️Ronald Pouyo z Uniwersytetu w Liege i firmy Bio-Techne.
A massive update: At least ~15 companies~ are selling scientists antibodies using faked validation data. We've documented 18,000+ manipulated images on 17,000+ products sold by leading laboratory suppliers including Thermo Fisher, Abcam, Santa Cruz Biotechnology, Millipore Sigma and Bio-Techne.
1/🧵
1/🧵
August 25, 2026 at 1:06 PM
A massive update: At least ~15 companies~ are selling scientists antibodies using faked validation data. We've documented 18,000+ manipulated images on 17,000+ products sold by leading laboratory suppliers including Thermo Fisher, Abcam, Santa Cruz Biotechnology, Millipore Sigma and Bio-Techne.
1/🧵
1/🧵
An absolute pleasure to work with all co-authors on this study: from @alessiociulli.bsky.social’s lab (the 🤝 House of VHL 🤝) @alesalerno.bsky.social & Gajanan Sathe – and our wonderful collaboration Graham Marsh and Hannah Maple from Tocris Bio-Techne
November 19, 2025 at 5:02 PM
An absolute pleasure to work with all co-authors on this study: from @alessiociulli.bsky.social’s lab (the 🤝 House of VHL 🤝) @alesalerno.bsky.social & Gajanan Sathe – and our wonderful collaboration Graham Marsh and Hannah Maple from Tocris Bio-Techne
Für zehn Milliarden Euro übernimmt der deutsche Merck-Konzern den US-Laborspezialisten Bio-Techne. Was dieses Geschäft so attraktiv macht – und welche Risiken es gibt.
Pharma: Merck baut die Werkzeuge für die nächste Revolution
Für zehn Milliarden Euro übernimmt der deutsche Merck-Konzern den US-Laborspezialisten Bio-Techne. Was dieses Geschäft so attraktiv macht – und welche Risiken es gibt.
www.wiwo.de
June 25, 2026 at 3:10 PM
Für zehn Milliarden Euro übernimmt der deutsche Merck-Konzern den US-Laborspezialisten Bio-Techne. Was dieses Geschäft so attraktiv macht – und welche Risiken es gibt.
Bio-Techne Introduces Innovative Tools for Spatial Biology Advancements#USA#Bio-Techne#Long_Beach#RNAscope#Lunaphore
Bio-Techne Introduces Innovative Tools for Spatial Biology Advancements
Discover how Bio-Techne is transforming translational research with new spatial biology solutions that bridge research and clinical applications effectively.
third-news.com
September 26, 2025 at 10:34 AM
Bio-Techne Introduces Innovative Tools for Spatial Biology Advancements#USA#Bio-Techne#Long_Beach#RNAscope#Lunaphore